有 关 个 别 药 物 或 某 类 别 药 物 的 安 全 资 讯
|
| |
| The United Kingdom: The benefits and risks of statins (English Only) |
| |
Medicines and Healthcare products Regulatory Agency (MHRA) published its position on the benefits and risks of statins, following the recent media coverage about side effects associated with them.
MHRA advised that people should continue to take their statins as prescribed. Large clinical trials have shown that statins can save lives by reducing the risk of heart attacks, strokes and the need for heart surgery. The benefits of taking statins strongly outweigh any risks. However like all medicines, statins can cause side effects in some people. Most side effects experienced by people who take statins are mild and product information lists advice on how to use statins and any potential side effects. If patients have any concerns about their medicines then they should speak to their doctor.
Please refer to the following website in MHRA for details:
http://www.mhra.gov.uk/NewsCentre/CON416702
In Hong Kong, there are 284 registered pharmaceutical products containing statins and they are all prescription-only medicines. Announcements on the safety of statins were previously reported by various health authorities including US, Canada, Australia, Singapore and China; and letters to inform local healthcare professionals on the announcements had been issued by DH. The safety of statins was also discussed by the Registration Committee of the Pharmacy and Poisons Board in December 2012. The Registration Committee decided that the sales pack labels and/or package inserts of statins-containing products should be updated to include new safety information. DH will continue to monitor the safety of statins; and will keep vigilant of new announcements on statins issued by overseas health authorities.
Ends/ Saturday, May 17, 2014
Issued at HKT 12:00
|
| |
|
